BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24778024)

  • 1. Formyl Peptide receptor 1 expression is associated with tumor progression and survival in gastric cancer.
    Cheng TY; Wu MS; Lin JT; Lin MT; Shun CT; Hua KT; Kuo ML
    Anticancer Res; 2014 May; 34(5):2223-9. PubMed ID: 24778024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor/extracellular signal-regulated kinase/integrin beta-1-binding protein 1 pathway.
    Cheng TY; Wu MS; Lin JT; Lin MT; Shun CT; Huang HY; Hua KT; Kuo ML
    Cancer; 2012 Dec; 118(23):5757-67. PubMed ID: 22736399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKR1B10, a good prognostic indicator in gastric cancer.
    Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
    Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
    Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
    Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis.
    Prevete N; Liotti F; Visciano C; Marone G; Melillo RM; de Paulis A
    Oncogene; 2015 Jul; 34(29):3826-38. PubMed ID: 25263443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
    J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
    Yang Q; Zhang C; Huang B; Li H; Zhang R; Huang Y; Wang J
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):953-7. PubMed ID: 23751352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
    Zhao ZS; Chu YQ; Ye ZY; Wang YY; Tao HQ
    Hum Pathol; 2010 May; 41(5):686-96. PubMed ID: 20060156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer.
    Shinmura K; Kiyose S; Nagura K; Igarashi H; Inoue Y; Nakamura S; Maeda M; Baba M; Konno H; Sugimura H
    J Surg Oncol; 2014 Mar; 109(3):189-97. PubMed ID: 24178904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectopic expression of MECA-79 as a novel prognostic indicator in gastric cancer.
    Okayama H; Kumamoto K; Saitou K; Hayase S; Kofunato Y; Sato Y; Miyamoto K; Nakamura I; Ohki S; Koyama Y; Ishii Y; Takenoshita S
    Cancer Sci; 2011 May; 102(5):1088-94. PubMed ID: 21281400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiles of Annexin A1, formylated peptide receptors and cyclooxigenase-2 in gastroesophageal inflammations and neoplasias.
    Takaoka RTC; Sertório ND; Magalini LPJ; Dos Santos LM; Souza HR; Iyomasa-Pilon MM; Possebon L; Costa SS; Girol AP
    Pathol Res Pract; 2018 Feb; 214(2):181-186. PubMed ID: 29254791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells.
    Arigami T; Uenosono Y; Hirata M; Yanagita S; Ishigami S; Natsugoe S
    Cancer Sci; 2011 May; 102(5):1019-24. PubMed ID: 21251161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of HER3 is associated with a decreased survival in gastric cancer.
    Hayashi M; Inokuchi M; Takagi Y; Yamada H; Kojima K; Kumagai J; Kawano T; Sugihara K
    Clin Cancer Res; 2008 Dec; 14(23):7843-9. PubMed ID: 19047113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of SPARC gene expression in patients with gastric cancer.
    Sato T; Oshima T; Yamamoto N; Yamada T; Hasegawa S; Yukawa N; Numata K; Kunisaki C; Tanaka K; Shiozawa M; Yoshikawa T; Akaike M; Rino Y; Imada T; Masuda M
    J Surg Oncol; 2013 Nov; 108(6):364-8. PubMed ID: 24018911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
    Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
    Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
    Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
    J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of protein expression signatures in gastric carcinomas using clustering analysis.
    Begnami MD; Fregnani JH; Brentani H; Torres C; Costa WL; Montagnini A; Nonogaki S; Soares FA
    J Gastroenterol Hepatol; 2012 Feb; 27(2):378-84. PubMed ID: 21777278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of osteopontin expression in human gastric carcinoma.
    Higashiyama M; Ito T; Tanaka E; Shimada Y
    Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.